Dyclocainum
Brand names,
Dyclocainum
Analogs
Dyclocainum
Brand Names Mixture
Dyclocainum
Chemical_Formula
C22H26N2O2S
Dyclocainum
RX_link
http://www.rxlist.com/cgi/generic3/relpax.htm
Dyclocainum
fda sheet
Dyclocainum
msds (material safety sheet)
Dyclocainum
Synthesis Reference
No information avaliable
Dyclocainum
Molecular Weight
382.52 g/mol
Dyclocainum
Melting Point
No information avaliable
Dyclocainum
H2O Solubility
Readily soluble as hydrobromide formulation
Dyclocainum
State
Solid
Dyclocainum
LogP
3.587
Dyclocainum
Dosage Forms
Tablet for oral administration (24.2 or 48.5 mg)
Dyclocainum
Indication
For the acute treatment of migraine with or without aura in adults.
Dyclocainum
Pharmacology
Eletriptan is a selective 5-hydroxytryptamine 1B/1D receptor agonist. In the anesthetized dog, eletriptan has been shown to reduce carotid arterial blood flow, with only a small increase in arterial blood pressure at high doses. While the effect on blood flow was selective for the carotid arterial bed, decreases in coronary artery diameter were observed. Eletriptan has also been shown to inhibit trigeminal nerve activity in the rat.
Dyclocainum
Absorption
Well absorbed after oral administration with a mean absolute bioavailability of approximately 50%.
Dyclocainum
side effects and Toxicity
Based on the pharmacology of the 5-HT1B/1D agonists, hypertension or other more serious cardiovascular symptoms could occur on overdose.
Dyclocainum
Patient Information
No information avaliable
Dyclocainum
Organisms Affected
Humans and other mammals